期刊文献+

贝那普利对小鼠自身免疫性心肌炎CCR2表达的影响 被引量:1

Effect of benazepril on CCR2 expression in experimental autoimmune myocarditis in mice
下载PDF
导出
摘要 目的探讨贝那普利对实验性自身免疫性心肌炎(EAM)小鼠心肌组织中CC趋化因子受体2(CCR2)表达的影响。方法60只BALB/c小鼠随机分为对照组、模型组、贝那普利组,每组20只。将提纯的猪心肌球蛋白和完全弗氏佐剂(CFA)等体积混合成乳浊液,模型组与贝那普利组小鼠按0.2ml/只皮下注射免疫,对照组则注射等体积PBS和CFA的混合液。初次免疫当天贝那普利组给予5mg/(kg.d)贝那利普灌胃,其余两组则给予等量生理盐水灌胃。分别于初次免疫后21、90d,比较各组的心重体重比、心肌炎症评分及血清cTnI测定,并采用RT-PCR及免疫组化检测小鼠心肌组织中CCR2的表达。结果21d时,模型组小鼠出现明显心肌炎性浸润,炎症评分、cTnI水平、CCR2mRNA表达(分别为2.49±0.53、2.99±0.80、0.61±0.12)明显高于对照组(分别为0、0.56±0.37、0.35±0.08,P<0.05),贝那普利组(分别为1.63±0.43、1.53±0.36、0.48±0.07)明显低于模型组(P<0.05),但仍高于对照组(P<0.05)。90d时,模型组小鼠心肌组织炎症减弱并伴有纤维化出现,心重体重比、炎症评分、CCR2mRNA表达(分别为5.08±0.09、0.83±0.41、0.49±0.07)明显高于对照组(分别为4.50±0.08、0、0.37±0.08,P<0.05)和贝那普利组(4.65±0.05,0.45±0.33、0.36±0.08,P<0.05),而贝那普利组心重体重比、炎症评分均高于对照组(P<0.05)。结论CCR2在EAM小鼠心肌中表达上调,并参与自身免疫性心肌炎的发生发展过程;贝那普利可以降低CCR2在EAM小鼠心肌中的表达,并抑制心肌炎症。 Objective To investigate the effect of benazepril on CCR2 expression in myocardium in mice with experimental autoimmune myocarditis (EAM).MethodsSixty BALB/c mice were randomly divided into control group,model group and benazepril group (20 each).The animals in model group and benazepril group were immunized with the emulsion of isovolumic complete Freund's adjuvant (CFA) and cardiac myosin extracted from porcine ventricular myocardium on day 0 and 7 to reproduce the model of experimental autoimmune myocarditis,and the mice in benazepril group were then given 5mg/(kg·d) benazepril by gavage.The mice in control group were immunized with CFA only.On days 21 and 90 after the first immunization,heart weight/body weight (HW/BW) was measured,HE staining was used to identify the areas of inflammation,the serum cTnI level was examined,and CCR2 expression was detected by immunohistochemistry and semi-quantitative RT-PCR.ResultsOn day 21,histopathological examination of cardiac tissue showed an obvious inflammatory cell infiltration with myocyte necrosis in model group.The inflammation score,cTnI level and the expression of CCR2 mRNA in model group (2.49±0.53,2.99±0.80 and 0.61±0.12,respectively) were higher than those in control group (0,0.56±0.37 and 0.35±0.08,respectively,P0.05),and those in benazepril group (1.63±0.43,1.53±0.36 and 0.48±0.07,respectively) were significantly lower than in model group (P0.05) but higher than in control group (P0.05).On day 90,fibrosis and a few inflammatory cells could be observed in model group,and the HW/BW,inflammation score and expression of CCR2 mRNA (5.08±0.09,0.83±0.41 and 0.49±0.07,respectively) were higher than those in control group (4.50±0.08,0 and 0.37±0.08,P0.05) and benazepril group (4.65±0.05,0.45±0.33 and 0.36±0.08,P0.05).HW/BW and inflammation score in benazepril group were higher than those in control group (P0.05).ConclusionsThe expression of CCR2 mRNA in myocardium is up-regulated in experimental autoimmune myocarditis.CCR2 may play an important role in the pathogenesis and development of autoimmune myocardtis.Benazepril can down-regulate the expression of CCR2 and inhibit cardiac inflammation.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2010年第2期155-158,162,共5页 Medical Journal of Chinese People's Liberation Army
关键词 受体 CCR2 贝那普利 心肌炎 自身免疫性 实验性 receptors CCR2 Benazepril myocarditis autoimmune experimental
  • 相关文献

参考文献13

  • 1Vergunst CE, Gerlag DM, Lopatinskaya L, et al. Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial[J]. Arthritis Rheum, 2008, 58(7) : 1931-1939.
  • 2Amoura Z, Combadiere C, Faure S, et al. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flaresp[J]. Arthritis Rheum, 2003, 48(12): 3487-3496.
  • 3Ali ZA, Bursill CA, Douglas G, etal. CCR2-mediated antiinflammatory effects of endothelial tetrahydrobiopterin inhibit vascular injuryinduced accelerated atherosclerosis [J ]. Circulation, 2008, 118 ( 14 Suppl) : S71-S77.
  • 4Liao TD, Yang XP, Liu YH, et al. Role of inflammation in the development of renal damage and dysfunction in angiotensin Ⅱ-indueed hypertension[J]. Hypertension, 2008, 52(2): 256-263.
  • 5徐梦丹,戴秋艳,孙宝贵.氯沙坦和替米沙坦保护靶器官与抑制单核细胞趋化蛋白1及受体2表达有关[J].中华高血压杂志,2007,15(9):735-740. 被引量:6
  • 6Murakami U, Uchida K, Hiratsuka T. Carcliac myosin from pig heart ventricle: purification and enzymatic properties[J]. J Biochem, 1976, 80(3): 611-619.
  • 7Cotton M, Claing A. G protein coupled receptors stimulation and the control of cell migration[J]. Cell Signal, 2009, 21(7): 1045-1053.
  • 8Sallusto F, Lanzavecchia A, Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses [J]. Immunol Today, 1998, 19(12): 568-574.
  • 9Sakai N, Wada T, Furuichi K, et al. MCP-1/CCR2-dependent lcop for fibrogenesis in human peripheral CD14 positive monocytes[J]. J Leukoc Biol, 2006, 79(3): 555-563.
  • 10Yamamoto T, Eckes B, Mauch C, et al. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metano proteinase-1 in human fibroblasts by an autocrine IL-1alpha loop[J]. J Immunol, 2000, 164(12) : 6174-6179.

二级参考文献17

  • 1李东野,周俊,丁茜,陈清枝,钱文浩,夏勇,潘德锋,史春志.赖诺普利与氯沙坦预防压力负荷性心肌肥厚的实验研究[J].江苏医药,2003,29(10):731-734. 被引量:2
  • 2赵丽,张翥.AngⅡ介导的高血压炎症反应机制[J].高血压杂志,2005,13(9):533-536. 被引量:11
  • 3鲍荣辉,刘先哲.单核细胞趋化蛋白研究进展[J].医学研究杂志,2006,35(4):58-60. 被引量:5
  • 4[1]Hilgers KF.Monocytes/marcrophages in hypertension[J].J Hypertens,2002,20:593-596.
  • 5[2]Mukaida N,Harada A,Matsushima K.Interleukin-8(IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1),chemokines essentially involved in inflammatory and immune reactions[J].Cytokine Growth Factor Rev,1998,9:9-23.
  • 6[4]Behr TM,Willette RN,Coatney RW,et al.Eprosartan improves cardiac performance,reduces cardiac hypertrophy and mortality and downregulates myocardial MCP-1 and inflammation in hypertensive heart disease[J].J Hypertens,2004,22:583-592.
  • 7[5]Watanabe T,Barker TA,Berk BC.Angiotensin Ⅱ and the endiothelium:diverse signals and effects[J].Hypertension,2005,45:163-169.
  • 8[6]Petnehazy T,Stokes KY,Russell,et al.Angiotensin Ⅱ type-1 receptor antagonism attenuates the inflammatory and thrombogenic responses to hypercholesterolemia in venules[J].Hypertension,2005,45:209-215.
  • 9[7]Schieffer B,Schieffer E,Hilfiker-Kleiner D,et al.Expression of angiotensin Ⅱ and interleukin 6 in human coronary atherosclerotic plaques:potential implications for inflammation and plaque instability[J].Circulation,2000,101:1372-1378.
  • 10[8]Nitenberg A.Hypertension,endothelial dysfunction and cardiovascular risk[J].Arch Mal Coeur Vaiss,2006,99:915-921.

共引文献5

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部